Derivatives of (p-carbonylaminophenyl) -sulfonyl-nitromethane.

The invention relates to novel derivatives (OXAMINOIDO-phenylsulfonyl) nitromethane and pharmaceutically acceptable salts thereof which are inhibitors of aldose reductase enzyme and are of value, FOR EXAMPLE, IN THE TREATMENT OF CERTAIN EFFECTS OF DIABETES AND PERIPHERALS galactosemia. ALSO DESCRIBED pharmaceutical compositions containing one DERIVATIVES AND PROCESSES FOR THE MANUFACTURE AND USE OF DERIVADOS.-